Quantamental Technologies LLC Denali Therapeutics Inc. Transaction History

Quantamental Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$23.37 - $32.96 $194,134 - $273,798	8,307 New	8,307 $245,000
Q4 2020 Feb 16, 2021	SELL	$36.89 - $93.56 $227,943 - $578,107	-6,179 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$23.13 - $38.84 $142,920 - $239,992	6,179 New	6,179 $221,000
Q1 2019 Apr 29, 2019	SELL	$17.99 - $24.65 $35,980 - $49,300	-2,000 Closed	0 $0
Q4 2018 Jan 28, 2019	BUY	$13.88 - $21.75 $27,760 - $43,500	2,000 New	2,000 $41,000

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.